← Browse by Condition
Medical Condition

large cell neuroendocrine carcinoma of the lung

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06736418 Phase 1
Recruiting

Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy

Enrollment
65 pts
Location
United States
Sponsor
Abdera Therapeutics Inc.
View Trial →